Clinical trial
Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
NCT05701774
Study timeline
Study start (actual)2023-01-31Date precision: day
Registry last updated2025-04-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prader-Willi Syndromeunresolved
Interventions
DCCRDRUG
Sponsors & collaborators
Soleno Therapeutics, Inc.lead sponsor
Mapped research locations
LondonUnited Kingdom2BostonMassachusetts, United States1DallasTexas, United States1AtlantaGeorgia, United States1NashvilleTennessee, United States1SeattleWashington, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1IndianapolisIndiana, United States1Salt Lake CityUtah, United States1BethesdaMaryland, United States1GainesvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05701774 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.